Strengthens international IP portfolio supporting development of triple-negative breast cancer therapy through 2040 ...
Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for ...
LEHI, Utah--(BUSINESS WIRE)--Pattern Group Inc. (Nasdaq: PTRN) (“Pattern”), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results